top of page
Insights for Life Sciences Talent Leaders
Strategic guidance on life sciences executive recruitment and human capital for search partners, biotech innovators, and scale-up HR leaders. I also share occasional personal reflections on the industry.


The True Cost of a Poor Senior Hire in Life Sciences
A poor senior hire in Life Sciences can cost far more than recruitment fees and replacement expenses. Delayed milestones, lost productivity, weakened trust, and reduced willingness to speak up can all affect organizational performance. This article explores the financial and cultural impact—and how to reduce the risk before making a pivotal appointment.
sharonshieldsconsu
6 days ago4 min read


Is “Culture Fit” Holding Back Diverse Talent in Specialty Pharma Leadership?
Ask any Specialty Pharma leader what they want in their next executive hire and you’ll hear familiar themes: “fresh thinking,” “diverse perspectives,” “ability to challenge the status quo.”
Then the search progresses, and a strong candidate gets rejected with a vague line: “They’re great, but I’m not sure they’re a culture fit.”
In many organizations, that is where diverse, high‑potential leaders—especially those who don’t look, talk, or network like the current C‑suite—qui
sharonshieldsconsu
Aug 86 min read


Bridging the Peaks and Valleys: Flexible Research Capability for Executive Search Firms
Executive search firms live with constant peaks and troughs in demand, creating pressure on research teams, margins, and delivery quality. This article explores how flexible research capability—blending strong in‑house teams with trusted external support—can help firms manage volatile workloads, protect consultant time, and maintain consistent standards without over‑hiring or risking burnout.
sharonshieldsconsu
Jul 274 min read


AI in Pharma: Bridging Research and Real-World Experience
If you read recent scientific reviews on artificial intelligence (AI) in the pharmaceutical industry, you get a clear message: AI is transforming drug discovery, clinical development, manufacturing, and safety.¹⁻⁵ However, if you talk to bench scientists, clinical teams, or data scientists over coffee, you often hear a more complicated story: pockets of impressive success, a lot of incremental improvements, and quite a few stalled pilots. Both perspectives are true. They’re j
sharonshieldsconsu
Jul 239 min read
bottom of page